ARHGAP1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.65401026208656E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.59619994578276E-09 |
Normal-vs-Stage2 |
1.849350E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.004500E-03 |
Stage1-vs-Stage2 |
7.855800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.832200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.013600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.09690034832965E-11 |
Normal-vs-AfricanAmerican |
5.480300E-02 |
Normal-vs-Asian |
1.008170E-02 |
Caucasian-vs-AfricanAmerican |
4.830300E-02 |
Caucasian-vs-Asian |
3.328600E-01 |
AfricanAmerican-vs-Asian |
9.612400E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.32810000003292E-06 |
Normal-vs-Female |
3.15759995928033E-09 |
Male-vs-Female |
2.854600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.964900E-04 |
Normal-vs-Extreme_Weight |
2.09640000026212E-07 |
Normal-vs-Obese |
2.058300E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.232400E-01 |
Normal_Weight-vs-Obese |
4.909800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.987200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.508230E-01 |
Normal-vs-Age(41-60Yrs) |
1.87654999999065E-05 |
Normal-vs-Age(61-80Yrs) |
1.35050000071857E-08 |
Normal-vs-Age(81-100Yrs) |
1.770020E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.234380E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.011800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.039630E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.882200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.389570E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.850400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.176380E-01 |
Normal-vs-Grade 3 |
7.687600E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.339400E-01 |
Grade 2-vs-Grade 4 |
1.176380E-01 |
Grade 3-vs-Grade 4 |
7.687600E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.99750224641571E-11 |
Normal-vs-N1 |
8.541700E-03 |
N0-vs-N1 |
6.020100E-02 |
|
|